Vivek P. Chavda

6.1k total citations · 4 hit papers
122 papers, 3.3k citations indexed

About

Vivek P. Chavda is a scholar working on Infectious Diseases, Molecular Biology and Pharmaceutical Science. According to data from OpenAlex, Vivek P. Chavda has authored 122 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Infectious Diseases, 29 papers in Molecular Biology and 12 papers in Pharmaceutical Science. Recurrent topics in Vivek P. Chavda's work include SARS-CoV-2 and COVID-19 Research (39 papers), COVID-19 Clinical Research Studies (26 papers) and RNA Interference and Gene Delivery (10 papers). Vivek P. Chavda is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (39 papers), COVID-19 Clinical Research Studies (26 papers) and RNA Interference and Gene Delivery (10 papers). Vivek P. Chavda collaborates with scholars based in India, Australia and United Kingdom. Vivek P. Chavda's co-authors include Lalitkumar K. Vora, Vasso Apostolopoulos, Hetvi K. Solanki, Amol D. Gholap, Thakur Raghu Raj Singh, Keshava Jetha, Rajashri Bezbaruah, Aayushi Patel, Pankti C. Balar and Vandana Patravale and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Controlled Release and Small.

In The Last Decade

Vivek P. Chavda

115 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Artificial Intelligence in Pharmaceutical Technology and Drug Delivery Design

2023 473 citations Lalitkumar K. Vora, Keshava Jetha et al. profile →
Tirzepatide, a New Era of Dual-Targeted Treatment for Diabetes and Obesity: A Mini-Review

2022 127 citations Vivek P. Chavda, Divya Teli et al. Molecules profile →
Essential oils for clinical aromatherapy: A comprehensive review

2024 53 citations Lalitkumar K. Vora, Vivek P. Chavda et al. profile →
Unveiling the promise: Exosomes as game‐changers in anti‐infective therapy

2024 42 citations Vivek P. Chavda, Guanghong Luo et al. SHILAP Revista de lepidopterología profile →

Peers

Countries citing papers authored by Vivek P. Chavda

Since Specialization

Citations

This map shows the geographic impact of Vivek P. Chavda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vivek P. Chavda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vivek P. Chavda more than expected).

Fields of papers citing papers by Vivek P. Chavda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vivek P. Chavda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vivek P. Chavda. The network helps show where Vivek P. Chavda may publish in the future.

Co-authorship network of co-authors of Vivek P. Chavda

This figure shows the co-authorship network connecting the top 25 collaborators of Vivek P. Chavda. A scholar is included among the top collaborators of Vivek P. Chavda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vivek P. Chavda. Vivek P. Chavda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Nanosuspensions: A new era of targeted therapeutics 2025 ·Journal of Drug Delivery Science and Technology ·Vivek P. Chavda, (unknown), Hetvi K. Solanki, Pankti C. Balar, (unknown), (unknown)	2
2	Unveiling resveratrol's potential: Navigating the landscape of autoimmune diseases 2024 ·Keshava Jetha, (unknown), (unknown), Jeet Gandhi, Vivek P. Chavda	3
3	Plant-derived exosomes in therapeutic nanomedicine, paving the path toward precision medicine 2024 ·Phytomedicine ·Min Zheng, Vivek P. Chavda, (unknown), Rajashri Bezbaruah, (unknown), (unknown), (unknown), Bairong Shen, Rajeev K. Singla	16
4	Nanoemulsions: Summary of a Decade of Research and Recent Advances 2024 ·Nanomedicine ·Vivek P. Chavda, Pankti C. Balar, Rajashri Bezbaruah, (unknown), (unknown), Bedanta Bhattacharjee, Vrashabh V. Sugandhi, Ana Cláudia Paiva‐Santos	14
5	Nature meets technology: Harnessing nanotechnology to unleash the power of phytochemicals 2024 ·Divya Teli, (unknown), (unknown), (unknown), (unknown), (unknown), Pankti C. Balar, (unknown), (unknown), (unknown), Vivek P. Chavda	20
6	Unveiling the promise: Exosomes as game‐changers in anti‐infective therapy breakdown → 2024 ·SHILAP Revista de lepidopterología ·Vivek P. Chavda, Guanghong Luo, Rajashri Bezbaruah, Tutumoni Kalita, Anupam Sarma, (unknown), Yanhong Duo, (unknown), (unknown), Humzah Postwala	42
7	A Review on the Impact of the SARS-CoV-2 Omicron Subvariant on Elderly Patients with Diverse Co-Morbidities 2023 ·SHILAP Revista de lepidopterología ·Avinash Khadela, (unknown), (unknown), (unknown), Vivek P. Chavda	3
8	Configuring Therapeutic Aspects of Immune Checkpoints in Lung Cancer 2023 ·Cancers ·Avinash Khadela, Vivek P. Chavda, Humzah Postwala, (unknown), Vasso Apostolopoulos, (unknown)	11
9	Parenteral microemulsions for drug delivery: Advances and update 2023 ·Journal of Drug Delivery Science and Technology ·Vivek P. Chavda, (unknown), (unknown), Pankti C. Balar, (unknown), (unknown)	14
10	Antibody–Biopolymer Conjugates in Oncology: A Review 2023 ·Molecules ·Vivek P. Chavda, Pankti C. Balar, Divya Teli, Majid Davidson, Joanna Bojarska, Vasso Apostolopoulos	15
11	Omicron Variant of SARS-CoV-2: An Indian Perspective of Vaccination and Management 2023 ·Vaccines ·Vivek P. Chavda, Pankti C. Balar, (unknown), (unknown), (unknown), (unknown), Lalitkumar K. Vora	13
12	Sunscreens: A comprehensive review with the application of nanotechnology 2023 ·Journal of Drug Delivery Science and Technology ·Vivek P. Chavda, (unknown), (unknown), (unknown), Lalitkumar K. Vora	64
13	Conventional and Novel Diagnostic Tools for the Diagnosis of Emerging SARS-CoV-2 Variants 2023 ·Vaccines ·Vivek P. Chavda, (unknown), Palak K. Parikh, (unknown), Abu Sufiyan Chhipa, (unknown), Snehal Patel, Pankti C. Balar, Ana Cláudia Paiva‐Santos, Vandana Patravale	21
14	Chlamydia trachomatis: quest for an eye-opening vaccine breakthrough 2022 ·Expert Review of Vaccines ·Vivek P. Chavda, Anjali Pandya, (unknown), Vandana Patravale, Vasso Apostolopoulos	5
15	An Impact of COVID-19 on Cancer Care: An Update 2022 ·Vaccines ·Vivek P. Chavda, (unknown), Zhe‐Sheng Chen	2
16	Recent review of COVID-19 management: diagnosis, treatment and vaccination 2022 ·Pharmacological Reports ·Vivek P. Chavda, (unknown), (unknown), (unknown), Aayushi Patel, (unknown), Zhe‐Sheng Chen	44
17	Herbal Remedies, Nutraceuticals, and Dietary Supplements for COVID-19 Management: An Update 2022 ·PubMed ·Vivek P. Chavda, Aayushi Patel, (unknown), (unknown), (unknown), (unknown), (unknown)	50
18	The Delta and Omicron Variants of SARS-CoV-2: What We Know So Far 2022 ·Vaccines ·Vivek P. Chavda, Rajashri Bezbaruah, (unknown), (unknown), Tutumoni Kalita	60
19	A Review on Novel Emulsification Technique: A Nanoemulsion 2017 ·Vivek P. Chavda, Dhaval A. Shah	13
20	CANNONBALL TREE: THE ALCHEMIST PLANT 2015 ·International Journal of Sciences ·Vivek P. Chavda	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact